About SeQuent
SeQuent is a company based in Bengaluru (India) founded in 2002 was acquired by The Carlyle Group in May 2020.. The company has 1,430 employees as of March 31, 2024. SeQuent has completed 1 acquisition, including Indo Phyto Chemicals. SeQuent offers products and services including APIs, FDFs, and Analytical Services. SeQuent operates in a competitive market with competitors including Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and Sterling Pharma Solutions, among others.
- Headquarter Bengaluru, India
- Employees 1430 as on 31 Mar, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Sequent Scientific Limited
-
Annual Revenue
$180.96 M (USD)13.23as on Mar 31, 2024
-
Net Profit
$2.56 M (USD)160.99as on Mar 31, 2024
-
EBITDA
$18.81 M (USD)147.59as on Mar 31, 2024
-
Latest Funding Round
$627.84 M (USD), Post-IPO
May 26, 2015
-
Investors
The Carlyle Group
& 2 more
-
Employee Count
1430
as on Mar 31, 2024
- Investments & Acquisitions
-
Acquired by
The Carlyle Group
(May 08, 2020)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of SeQuent
SeQuent is a publicly listed company on the NSE with ticker symbol SEQUENT in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of SeQuent
SeQuent offers a comprehensive portfolio of products and services, including APIs, FDFs, and Analytical Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Active ingredients for veterinary medications
Finished dosage forms for animal health care
Testing and analysis for animal health products
Unlock access to complete
Funding Insights of SeQuent
- Total Funding Total Funding
- Total Rounds 2
- Last Round Post-IPO — $627.8M
-
First Round
First Round
(01 Apr 2014)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2015 | Amount | Post-IPO - SeQuent | Valuation |
investors |
|
| Apr, 2014 | Amount | Post-IPO - SeQuent | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in SeQuent
SeQuent has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include The Carlyle Group and Ascent Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
AscentCapital is engaged in potato farming, grain marketing, and equipment services in Maine.
|
Founded Year | Domain | Location | |
|
Private equity investments are directed toward multiple sectors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by SeQuent
SeQuent has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Indo Phyto Chemicals. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Manufacturer & supplier of active pharmaceutical ingredients
|
1978 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - SeQuent
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Sequent Comparisons
Competitors of SeQuent
SeQuent operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and Sterling Pharma Solutions, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Pharmaceutical and biotechnology company
|
|
| domain | founded_year | HQ Location |
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
|
|
| domain | founded_year | HQ Location |
APIs and drug products are developed and valorized in pharmaceuticals.
|
|
| domain | founded_year | HQ Location |
APIs, intermediates, and biochemical reagents are developed and manufactured.
|
|
| domain | founded_year | HQ Location |
Contract development, manufacturing, and analytical services for APIs are offered.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Sequent
Frequently Asked Questions about SeQuent
When was SeQuent founded?
SeQuent was founded in 2002 and raised its 1st funding round 12 years after it was founded.
Where is SeQuent located?
SeQuent is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
How many employees does SeQuent have?
As of Mar 31, 2024, the latest employee count at SeQuent is 1,430.
What is the annual revenue of SeQuent?
Annual revenue of SeQuent is $180.96M as on Mar 31, 2024.
What does SeQuent do?
SeQuent was established in 2002 in Bengaluru, India, focusing on the pharmaceutical sector. Active pharmaceutical ingredients (APIs) are produced for various therapeutic areas through three manufacturing facilities located in Karnataka and Maharashtra. Contract research services are provided by its research arm, SeQuent Research Limited, specializing in analytical and bioanalytical support for API, pharmaceutical, personal care, and nutraceutical companies.
Who are the top competitors of SeQuent?
SeQuent's top competitors include Laurus Labs, Symbiotec and Beijing Biostar Technologies.
What products or services does SeQuent offer?
SeQuent offers APIs, FDFs, and Analytical Services.
Is SeQuent publicly traded?
Yes, SeQuent is publicly traded on NSE under the ticker symbol SEQUENT.
How many acquisitions has SeQuent made?
SeQuent has made 1 acquisition, including Indo Phyto Chemicals.
Who are SeQuent's investors?
SeQuent has 2 investors. Key investors include The Carlyle Group, and Ascent Capital.
What is SeQuent's ticker symbol?
The ticker symbol of SeQuent is SEQUENT on NSE.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.